Sensorygen

About:

Sensorygen discover natural compounds to replace toxic/harsh chemicals in products through computational biology.

Website: https://sensorygen.com/

Top Investors: Berkeley Angel Network

Description:

Sensorygen discover natural compounds to replace toxic/harsh chemicals in products through computational biology. Approximately 1 billion people are at risk of insect bites and transmitted diseases, while 30% of the global agricultural output is destroyed by insects. Altogether this represents nearly a trillion dollars in loss each year. The company focus is to use cutting edge research toward finding effective and safe insect repellants. With their technology, they are building on a new generation of broad-spectrum insect repellents for protecting humans, their homes, their pets, stored products, and crops. A common problem inherent in the flavors and fragrances industry is the reliance on antiquated techniques in order to evaluate new odors for use in consumer products and evaluating the character of those odors using subjective descriptions. Sensorygen, eliminates much of the work and cost involved in evaluating small molecules using their highly accurate in silico screening platforms, narrowing down 400,000+ potential odor candidates to hundreds. The company was founded in 2013 by Dr. Anandasankar Ray.

Total Funding Amount:

$814000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

South Pasadena, California, United States

Founded Date:

2014-01-01

Founders:

Anandasankar Ray

Number of Employees:

1-10

Last Funding Date:

2019-04-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai